Flexion Therapeutics, Inc. (NASDAQ:FLXN) Posts Basic Consolidated EPS Of $-2.1545

0

Flexion Therapeutics, Inc. (NASDAQ:FLXN)managed to report annual basic consolidated EPS of $-2.1545, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-2.1545 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.6258.

EPS contribution from parent

Flexion Therapeutics, Inc. (NASDAQ:FLXN) received of $-2.1545 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Flexion Therapeutics, Inc. (NASDAQ:FLXN) contributed EPS of $-2.1545 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-2.1545.

What About Basic net EPS

The basic net EPS that Flexion Therapeutics, Inc. (NASDAQ:FLXN) reported for the year ended 2015-12-31 stood at $-2.15. For the quarter ended 2015-12-31, the company posted basic net EPS of $-2.15.

What About Consolidated Diluted EPS?

Flexion Therapeutics, Inc. (NASDAQ:FLXN)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-2.1545. For the quarter ended 2015-12-31 the metric was$-2.1545.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-2.1545 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-2.1545.

Net diluted EPS

Net diluted EPS posted by Flexion Therapeutics, Inc. (NASDAQ:FLXN) for the year ended 2015-12-31 was $-2.15. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-2.15.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Flexion Therapeutics, Inc. (NASDAQ:FLXN) said that it parent company boosted its diluted EPS by$-2.1545 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-2.1545.

The company reported net basic EPS of $-2.15 for the year ended 2015-12-31 and net basic EPS of $-2.15 for the quarter ended 2015-12-31.

The number of Flexion Therapeutics, Inc. (NASDAQ:FLXN)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 21.497. That compares with 21.497 basic shares outstanding for the quarter ended 2015-12-31.

Flexion Therapeutics, Inc. (NASDAQ:FLXN) had 21.497 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 21.497.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 35 times, 1 visits today)